Senior Management in higher education and international growth industries
Higher education, international business, theater, opera, sports, cross-cultural management, global politics...
4 year BA program
History and Economics
2 year MBA program with emphasis on marketing
Professor of Marketing - CERAM ESC Nice (now SKEMA) Provence, FRANCE Director of MBA Programs
Full Professor and Director of MBA Programs in French Grande Ecole of management training (CERAM = Center for Education and Research Applied to Management). As Director of MBA programs responsibilities included design and marketing of executive education and business administration training programs to multinational companies operating throughout Europe. Established joint global MBA Program with the University of Phoenix (US) and the Shanghai Institute of Foreign Trade (PRC). Also served as Head of Marketing Department in CERAM’s French MIM (Master in Management) Program. The CERAM MBA Program was developed to a rating among the “Top Ten” in French business schools.
Chief Executive Officer - TREMA Group NV Boston / Stockholm
Chief Executive and Management Board member of leading provider of strategic software solutions to the global financial industry. Trema’s flagship product, FinanceKit, is a straight-through-processing (STP) treasury, risk, and asset management software system for UNIX and Microsoft Windows NT, operating automatically and in real time on an integrated front/middle/back office platform. Trema clients include key players in international financial markets, including DekaBank, Bankgesellschaft Berlin, Central Bank of Greece, Central Bank of Turkey, South African Reserve Bank, ABB, ABN Amro, BMW Group, CEMEX, Electrolux, Ericsson, ING Investment Management, Johnson Controls, Pharmacia/Upjohn, Unilever, and Volvo. Trema is a European-based enterprise operating in 11 countries, with corporate headquarters in Stockholm and primary software development laboratories on the French Cote d’Azur and in Prague, Czech Republic. During my tenure as CEO , sales revenues were grown from €28mm to €93mm per annum, and the company was prepared for its IPO on the “Neuer Markt” of the Frankfurt Stock Exchange.
Chief Executive Officer - OPTAx Systems Inc. Boston / Stockholm
CEO, President, and Management Board member of a company operating in partnership with Harvard Medical School / McLean Hospital to distribute and market a unique test for ADHD (Attention-Deficit Hyperactivity Disorder) in children, adolescents, and adults. The company owns proprietary rights to the Harvard ADHD test and a stream of other neuropsychiatric disorder testing procedures developed at McLean Hospital in Belmont, Massachusetts. Subsequent to clinical trials and Beta testing in the U.S. and Northern Europe, the company began commercial rollout of test systems to psychiatrists, neurologists, pediatricians, and psychologists worldwide.
Numerous press releases and marketing related presentations were produced in various business sectors over a 30-year commercial and academic career. Press releases were written and delivered via various media channels, including newspapers, magazines, business publications and journals, and regulatory entities.